Esperion Therapeutics
ESPR
#6506
Rank
A$1.23 B
Marketcap
A$4.80
Share price
0.00%
Change (1 day)
27.51%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2026 (TTM): A-$0.02876

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.03022. In 2025 the company made an earnings per share (EPS) of A-$0.20 an increase over its 2024 EPS that were of A-$0.35.

EPS history for Esperion Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.02876-85.36%
2025A-$0.20-43.48%
2024A-$0.35-89.15%
2023A-$3.20-40.28%
2022A-$5.36-62.87%
2021A-$14.4480.38%
2020A-$8.0150.14%
2019A-$5.33-53.18%
2018A-$11.397.41%
2017A-$10.61110.81%
2016A-$5.0347.35%
2015A-$3.410.89%
2014A-$3.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.07-3,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$70.98-235,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$7.84 25,850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A-$0.21 600.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.17 450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A-$0.14 350.00%๐Ÿ‡บ๐Ÿ‡ธ USA